The pooled data revealed that increased MALAT1 expression was significantly associated with poor OS, DFS and RFS, indicating that MALAT1 has been shown to contribute to cancer progression and considered as a promising prog-nostic biomarker for cancer patients. The gene discussed is MALAT1; the disease is cancer.